A systematic review of the literature published until August 2018 was performed in eight databases with two independent reviewers assessing quality. Seventeen articles were identified as relevant and a draft guideline was developed in the form of action statements. A total of 10 physical therapists with hematology experience and 10 patients with MM were recruited for consensus process. A priori threshold of 80% agreement was used to establish a consensus for each statement. The draft guidelines were reviewed externally by four methodologists using the AGREE II tool and a stakeholder representing OH (Cancer Care Ontario) Program in Evidence Based Care (PEBC), McMaster University. The final guideline was reviewed and officially endorsed by the Canadian Physiotherapy Association.
A total of 30 action statements were developed that achieved consensus, indicating physical therapy recommendations based on physiological markers (ie, hemoglobin, platelet count), complete patient presentation, and the stage of medical treatment.
These clinical practice guidelines were developed to aid physical therapists in implementing evidence-based and best-practice care for patients with MM in order to optimize rehabilitation outcomes.
The Author(s) 2020. Published by Oxford University Press on behalf of the American Physical Therapy Association.